Abstract
Substance use disorders (SUD) represent a public health crisis worldwide. The development of effective pharmacotherapeutics to treat drug abuse and addiction requires the identification of targetable neurobiological mechanisms. As the primary excitatory neurotransmitter in the brain glutamate possesses a significant role in plasticity, learning, and memory, and represents a promising neurotransmitter of focus for intervention in the etiology of SUDs. Chronic drug exposure induces lasting neuroadaptations in the glutamatergic system specifically within the mesocorticolimbic (MCL) reward pathway which is posited to generate maladaptive deficits in behavioral-control, thus contributing to the addictive cycle. Maintaining the strict control of glutamate release and clearance is required for homeostasis as well as the prevention of neurotoxicity and oxidative stress. There are five excitatory amino acid transporters (EAATs) and three vesicular glutamate transporters. These function to preserve homeostatic levels of glutamate under normal physiological conditions. This review aims to highlight and summarize the preclinical evidence for dysregulation of glutamate transport following drug exposure. Additionally, alterations in glutamate transporters, with an emphasis on glutamate transporter 1 (EAAT2 encodes by SLC1A2) and its role in the development of detrimental drug-seeking behaviors, as well as current glutamate transporter-associated treatments being investigated are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aal-Aaboda M, Alhaddad H, Osowik F, Nauli SM, Sari Y (2015) Effects of (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol-preferring rats. J Neurosci Res 93:930–937
Abulseoud OA, Miller JD, Wu J, Choi DS, Holschneider DP (2012) Ceftriaxone upregulates the glutamate transporter in medial prefrontal cortex and blocks reinstatement of methamphetamine seeking in a condition place preference paradigm. Brain Res 1456:14–21
Abulseoud OA, Camsari UM, Ruby CL, Kasasbeh A, Choi S, Choi DS (2014) Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2. Neuropsychopharmacology 39:1674–1684
Alajaji M, Bowers MS, Knackstedt L, Damaj MI (2013) Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice. Psychopharmacology 228(3):419–426
Alasmari F, Abuhamdah S, Sari Y (2015) Effects of ampicillin on cystine/glutamate antiporter and glutamate transporter 1 isoforms as well as ethanol drinking in male P rats. Neurosci Lett 600:148–152
Alasmari F, Rao PSS, Sari Y (2016) Effects of cefazolin and cefoperazone on glutamate transporter 1 isoforms and cystine/glutamate exchanger as well as alcohol drinking behavior in male alcohol-preferring rats. Brain Res 1634:150–157
Alasmari F, Goodwani S, McCullumsmith RE, Sari Y (2018a) Role of glutamatergic system and mesocorticolimbic circuits in alcohol dependence. Prog Neurobiol 171:32–49
Alasmari F, Bell RL, Rao PSS, Hammad AM, Sari Y (2018b) Peri-adolescent drinking of ethanol and/or nicotine modulates astroglial glutamate transporters and metabotropic glutamate receptor-1 in female alcohol-preferring rats. Pharmacol Biochem Behav 170:44–55
Alhaddad H, Das SC, Sari Y (2014a) Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats. Psychopharmacology 231:4049–4057
Alhaddad H, Kim NT, Aal-Aaboda M, Althobaiti YS, Leighton J, Boddu SH, Wei Y, Sari Y (2014b) Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats. Front Behav Neurosci 8:366
Alonso-Nanclares L, De Felipe J (2005) Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex. Neuroscience 134(1):59–68
Alshehri FS, Althobaiti YS, Sari Y (2017) Effects of administered ethanol and methamphetamine on glial glutamate transporters in rat striatum and hippocampus. J Mol Neurosci 61:343–350
Alshehri FS, Hakami AY, Althobaiti YS, Sari Y (2018) Effects of ceftriaxone on hydrocodone seeking behavior and glial glutamate transporters in P rats. Behav Brain Res 347:368–376
Althobaiti YS, Almalki AH, Das SC, Alshehri FS, Sari Y (2016a) Effects of repeated high-dose methamphetamine and ceftriaxone post-treatments on tissue content of dopamine and serotonin as well as glutamate and glutamine. Neurosci Lett 634:25–31
Althobaiti YS, Alshehri FS, Almalki AH, Sari Y (2016b) Effects of ceftriaxone on glial glutamate transporters in Wistar rats administered sequential ethanol and methamphetamine. Front Neurosci 10:427
Althobaiti YS, Alshehri FS, Hakami AY, Hammad AM, Sari Y (2019) Effects of clavulanic acid treatment on reinstatement to methamphetamine, glial glutamate transporters, and mGluR 2/3 expression in P rats exposed to ethanol. J Mol Neurosci 67(1):1–15
Amen SL, Piacentine LB, Ahmad ME, Li SJ, Mantsch JR, Risinger RC, Baker DA (2011) Repeated N-acetyl cysteine reduces cocaine seeking in rodents and craving in cocaine-dependent humans. Neuropsychopharmacology 36(4):871–878
Arriza JL, Eliasof S, Kavanaugh MP, Amara SG (1997) Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to chloride conductance. Proc Natl Acad Sci USA 94:4155–4160
Aschner M, Syversen T, Souza DO, Rocha JBT, Farina M (2007) Involvement of glutamate and reactive oxygen species in methylmercury neurotoxicity. Braz J Med Biol Res 40:285–291
Baker DA, McFarland K, Lake RW, Shen H, Toda S, Kalivas PW (2003) N-acetyl cysteine-induced blockade of cocaine-induced reinstatement. Ann N Y Acad Sci 1003:349–351
Balazsfi D, Fodor A, Torok B, Ferenczi S, Kovacs KJ, Haller J, Zelena D (2018) Enhanced innate fear and altered stress axis regulation in VgluT3 knockout mice. Stress 21(2):151–161
Bannai S (1984) Transport of cystine and cysteine in mammalian cells. Biochim Biophys Acta 779:289–306
Bannai S, Ishii T (1982) Transport of cystine and cysteine and cell growth in cultured human diploid fibroblasts: effect of glutamate and homocysteate. J Cell Physiol 112:265–272
Basavarajappa BS, Ninan I, Arancio O (2008) Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. J Neurochem 107:1001–1013
Bechard AR, Knackstedt LA (2019) The effects of Pavlovian cue extinction and ceftriaxone on cocaine relapse after abstinence. Drug Alcohol Depend 197:83–86
Bechard AR, Hamor PU, Schwendt M, Knackstedt LA (2018) The effects of ceftriaxone on cue-primed reinstatement of cocaine-seeking in male and female rats: estrous cycle effects on behavior and protein expression in the nucleus accumbens. Psychopharmacology 235(3):837–848
Bell RL, Sable HJK, Colombo G, Hyytia P, Rodd ZA, Lumeng L (2012) Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity. Pharmacol Biochem Behav 103:119–155
Bell RL, Franklin KM, Hauser SR, Engleman EA (2013) Next stop dependence. Binge drinking on the road to alcoholism: preclinical findings on its neurobiology from rat animal models. In: Harris SB (ed) Binge eating and binge drinking: psychological, social and medical implications. Nova Science Publishers, New York, pp 1–60
Bell RL, Rodd ZA, Engleman EA, Toalston JE, McBride WJ (2014) Scheduled access alcohol drinking by alcohol-preferring (P) and high alcohol-drinking (HAD) rats: modeling adolescent and adult binge-like drinking. Alcohol 48(3):225–234
Bell RL, Hauser SR, McClintick J, Rahman S, Edenberg HJ, Szumlinski KK, McBride WJ (2016a) Ethanol-associated changes in glutamate reward neurocircuitry: a mini-review of clinical and preclinical genetic findings. Prog Mol Biol Transl Sci 137:41–85
Bell RL, Hauser S, Rodd ZA, Liang T, Sari Y, McClintick J, Rahman S, Engleman EA (2016b) A genetic animal model of alcoholism for screening medications to treat addiction. Int Rev Neurobiol 126:179–261
Bell RL, Hauser SR, Liang T, Sari Y, Maldonado-Devincci A, Rodd ZA (2017) Rat animal models for screening medications to treat alcohol use disorders. Neuropharmacology 122:201–243
Bell RL, Sari Y, Rahman S (2019) Alcohol and central glutamate activity: what goes up must come down? In: Preedy VR (ed) The neuroscience of alcohol: mechanisms and treatment. Elsevier, New York, pp 453–462
Bellesi M, Conti F (2010) The mGluR2/3 agonist LY379268 blocks the effects of GLT-1 upregulation on prepulse inhibition of the startle reflex in adult rats. Neuropsychopharmacology 35:1253–1260
Bellocchio EE, Reimer RJ, Fremeau RT Jr, Edwards RH (2000) Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289(5481):957–960
Berk M, Malhi GS, Gray LJ, Dean OM (2013) The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 34(3):167–177
Beschorner R, Simon P, Schauer N, Mittelbronn M, Schluesener HJ, Trautmann K, Dietz K, Meyermann R (2007) Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a neuroprotective potential following ischaemia. Histopathology 50:897–910
Bhatti J, Nascimento B, Akhtar U, Rhind SG, Tien H, Nathens A, da Luz LT (2017) Systematic review of human and animal studies examining the efficacy and safety of N-acetylcysteine (NAC) and N-acetylcysteine amide (NACA) in traumatic brain injury: impact on neurofunctional outcome and biomarkers of oxidative stress and inflammation. Front Neurol 8:744
Bossong MG, Wilson R, Appiah-Kusi E, McGuire P, Bhattacharyya S (2018) Human striatal response to reward anticipation linked to hippocampal glutamate levels. Int J Neuropsychopharmacol 27:623–630
Bowers MS, Jackson A, Maldoon PP, Damaj MI (2016) N-acetylcysteine decreased nicotine reward-like properties and withdrawal in mice. Psychopharmacology 233(6):995–1003
Bridges CC, Kekuda R, Wang H, Prasad PD, Mehta P, Huang W, Smith SB, Ganapathy V (2001) Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 42:47–54
Bridges R, Lutgen V, Lobner D, Baker DA (2012) Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacol Rev 64:780–802
Bröer S, Brookes N (2001) Transfer of glutamine between astrocytes and neurons. J Neurochem 77(3):705–719
Brown RM, Kupchik YM, Kalivas PW (2013) The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy. JAMA Psychiatry 70(9):895–897
Carbone M, Duty S, Rattray M (2012) Riluzole elevates GLT-1 activity and levels in striatal astrocytes. Neurochem Int 60:31–38
Chaudhry FA, Schmitz D, Reimer RJ, Larsson P, Gray AT, Nicoll R, Kavanaugh M, Edwards RH (2002a) Glutamine uptake by neurons: interaction of protons with system a transporters. J Neurosci 22:62–72
Chaudhry FA, Reimer RJ, Edwards RH (2002b) The glutamine commute: take the N line and transfer to the A. J Cell Biol 157:349–355
Cools R, Nakamura K, Daw ND (2011) Serotonin and dopamine: unifying affective, activational, and decision functions. Neuropsychopharmacology 36:98–113
Cooper S, Robinson AJ, Mazei-Robison MS (2017) Reward circuitry in addiction. Neurotherapeutics 14:687–697
Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
Das SC, Yamamoto BK, Hristov AM, Sari Y (2015) Ceftriaxone attenuates ethanol drinking and restores extracellular glutamate concentration through normalization of GLT-1 in nucleus accumbens of male alcohol-preferring rats. Neuropharmacology 97:67–74
Deitmer JW, Bröer A, Bröer S (2003) Glutamine efflux from astrocytes is mediated by multiple pathways. J Neurochem 87(1):127–135
Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci 85:5274–5278
Ducret E, Puaud M, Lacoste J, Belin-Rauscent A, Fouyssac M, Dugast E, Murray JE, Everitt BJ, Houeto JL, Belin D (2016) N-acetylcysteine facilitates self-imposed abstinence after escalation of cocaine intake. Biol Psychiatry 80(3):226–234
Eastwood SL, Harrison PJ (2005) Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73(2–3):159–172
Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara SG (1995) An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375:599–603
Floresco SB (2015) The nucleus accumbens: an interface between cognition, emotion, and action. Annu Rev Psychol 66:25–52
Floresco SB, Todd CL, Grace AA (2001) Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of the ventral tegmental area dopamine neurons. J Neurosci 21:4915–4922
Floresco SB, West AR, Ash B, Moore H, Grace AA (2003) Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6:968–973
Frankowska M, Jastrzębska J, Nowak E, Białko M, Przegaliński E, Filip M (2014) The effects of N-acetylcysteine on cocaine reward and seeking behaviors in a rat model of depression. Behav Brain Res 266:108–118
Froeliger B, McConnell PA, Stankeviciute N, McClure EA, Kalivas PW, Gray KM (2015) The effects of N-Acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence: A double-blind, placebo-controlled fMRI pilot study. Drug Alcohol Depend 156:234–242
Fujio M, Nakagawa T, Sekiya Y, Ozawa T, Suzuki Y, Minami M, Satoh M, Kaneko S (2005) Gene transfer of GLT-1, a glutamate transporter, into the nucleus accumbens shell attenuates methamphetamine- and morphine-induced conditioned place preference in rats. Eur J Neurosci 22(11):2744–2754
Garcia-Keller C, Smiley C, Monforton C, Melton S, Kalivas PW, Gass J (2019) N-Acetylcysteine treatment during acute stress prevents stress-induced augmentation of addictive drug use and relapse. Addict Biol 7:e12798
Gass JT, Chandler LJ (2013) The plasticity of extinction: contribution of the prefrontal cortex in treating addiction through inhibitory learning. Front Psychiatry 4:1–13
Gipson CD, Reissner KJ, Kupchik YM, Smith AC, Stankeviciute N, Hensley-Simon ME, Kalivas PW (2013) Reinstatement of nicotine seeking is mediated by glutamatergic plasticity. Proc Natl Acad Sci U S A 110(22):9124–9129
Goenaga J, Powell GL, Leyrer-Jackson JM, Piña J, Phan S, Prakapenka AV, Koebele SV, Namba MD, McClure EA, Bimonte-Nelson HA, Gipson CD (2020) N-acetylcysteine yields sex-specific efficacy for cue-induced reinstatement of nicotine seeking. Addict Biol 25(1):e12711
Goodwani S, Rao PS, Bell RL, Sari Y (2015) Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions. Brain Res 1622:397–408
Gourley SL, Taylor JR (2016) Going and stopping: dichotomies in behavioral control by the prefrontal cortex. Nat Rev Neurosci 19:656–664
Grewer C, Gameiro A, Zhang Z, Tao Z, Braams S, Rauen T (2008) Glutamate forward and reverse transport: from molecular mechanism to transporter-mediated release after ischemia. IUBMB Life 60(9):609–619
Habibi-Asl B, Vaez H, Najafi M, Bidaghi A, Ghanbarzadeh S (2014) Attenuation of morphine-induced dependence and tolerance by ceftriaxone and amitriptyline in mice. Acta Anaesthesiology Taiwan 52(4):163–168
Hakami AY, Sari Y (2017) β-Lactamase inhibitor, clavulanic acid, attenuates ethanol intake and increases glial glutamate transporters expression in alcohol preferring rats. Neurosci Lett 657:140–145
Hakami AY, Hammad AM, Sari Y (2016) Effects of amoxicillin and Augmentin on Cystine-glutamate exchanger and glutamate transporter 1 isoforms as well as ethanol intake in alcohol-preferring rats. Front Neurosci 10:171
Hakami AY, Alshehri FS, Althobaiti YS, Sari Y (2017) Effects of orally administered Augmentin on glutamate transporter 1, cystine-glutamate exchanger expression and ethanol intake in alcohol-preferring rats. Behav Brain Res 320:316–322
Hammad AM, Sari Y (2020) Effects of cocaine exposure on astrocytic glutamate transporters and relapse-like ethanol-drinking behavior in male alcohol-preferring rats. Alcohol 55:254–263
Hammad AM, Alasmari F, Althobaiti YS, Sari Y (2017) Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior. Behav Brain Res 332:288–298
Hayashi MK (2018) Structure-function relationship of transporters in the glutamate-glutamine cycle of the central nervous system. Int J Mol Sci 19(4):E1177
Hu WH, Walters WM, Xia XM, Karmally SA, Bethea JR (2003) Neuronal glutamate transporter EAAT4 is expressed in astrocytes. Glia 44(1):13–25
Huggett JF, Mustafa A, O’Neal L, Mason DJ (2002) The glutamate transporter GLAST-1 (EAAT-1) is expressed in the plasma membrane of osteocytes and is responsive to extracellular glutamate concentration. Biochem Soc Trans 30:890–893
Israel Y, Quintanilla ME, Ezquer F, Morales P, Santapau D, Berríos-Cárcamo P, Ezquer M, Olivares B, Herrera-Marschitz M (2019) Aspirin and N-acetylcysteine co-administration markedly inhibit chronic ethanol intake and block relapse binge drinking: Role of neuroinflammation-oxidative stress self-perpetuation. Addict Biol 15:e12853
Ito K, Abekawa T, Koyama T (2006) Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine. Psychopharmacology 187:293–302
Javitt DC, Schoepp D, Kalivas PW, Volkow ND, Zarate C, Merchant K, Bear MF, Umbricht D, Hajos M, Potter WZ, Lee CM (2011) Translating glutamate: from pathophysiology to treatment. Sci Transl Med 3:102mr2
Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561–572
Kalivas PW, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3(8):760–773
Kangas BD, Doyle RJ, Kohut SJ, Bergman J, Kaufman MJ (2019) Effects of chronic cocaine self-administration and N-acetylcysteine on learning, cognitive flexibility, and reinstatement in non-human primates. Psychopharmacology 236(7):2143–2153
Karki P, Kim C, Smith K, Son D-S, Aschner M, Lee E (2015) Transcriptional regulation of the astrocytic excitatory amino acid transporter 1 (EAAT1) via NF-kB and Yin Yang 1 (YY1). J Biol Chem 290:23725–23737
Kauer JA, Malenka RC (2007) Synaptic plasticity and addiction. Nat Rev Neurosci 8(11):844–858
Kelley AE (1999) Functional specificity of the ventral striatal compartments in appetitive behaviors. Annal of the New York Academy of Sciences 29:71–90
Kim J, John J, Langford D, Walker E, Ward S, Rawls SM (2016) Clavulanic acid enhances glutamate transporter subtype I (GLT-1) expression and decreases reinforcing efficacy of cocaine in mice. Amino Acids 48(3):689–696
Knackstedt LA, LaRowe S, Merdikian P, Malcolm R, Upadhyaya H, Hedden S, Markou A, Kalivas PW (2009) The role of cysteine glutamate exchange in nicotine dependence in rat and humans. Biol Psychiatry 65:841–845
Knackstedt LA, Moussawi K, Lalumiere R, Schwendt M, Klugmann M, Kalivas PW (2010) Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking. J Neurosci 30:7984–7992
Koob GF (2013) Negative reinforcement in drug addiction: the darkness within. Curr Opin Neurobiol 23:559–563
Koob GF, Volkow ND (2016) Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3:760–773
Koob GF, Arends MA, LeMoal M (2014) Drugs, addiction, and the brain. Elsevier, Waltham, MA
Kupchik YM, Moussawi K, Tang XC, Wang X, Kalivas BC, Kolokithas R, Ogburn KB, Kalivas PW (2012) The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry 71(11):978–986
Labarca R, Gajardo MI, Seguel M, Silva H, Jerez S, Ruiz A, Bustos G (1995) Effects of D-amphetamine administration on the release of endogenous excitatory amino acids in the rat nucleus accumbens. Prog Neuro-Psychopharmacol Biol Psychiatry 19:467–473
LaCrosse AL, Hill K, Knackstedt LA (2016) Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression. Eur Neuropsychopharmacol 26:186–194
Lan YL, Zhao J, Li S (2014) Estrogen receptors’ neuroprotective effect against glutamate-induced neurotoxicity. Neurol Sci 35:1657–1662
LaRowe SD, Kalivas PW (2010) The role of N-acetylcysteine in inhibiting responding during extinction in rats trained to self-administer cocaine. Open Addict J 3:88–91
LaRowe SD, Kalivas PW, Nicholas JS, Randall PK, Mardikian PN, Malcolm RJ (2013) A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict 22(5):443–452
Lebourgeois S, González-Marín MC, Antol J, Naassila M, Vilpoux C (2019) Evaluation of N-acetylcysteine on ethanol self-administration in ethanol-dependent rats. Neuropharmacology 150:112–120
Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 15:1835–1853
Leriche M, Mendez M, Zimmer L, Berod A (2008) Acute ethanol induces Fos in GABAergic and non-GABAergic forebrain neurons: a double-labeling study in the medial prefrontal cortex and extended amygdala. Neuroscience 153:259–267
Levi Bolin B, Alcorn JL III, Lile JA, Rush CR, Rayapati AO, Hays LR, Stoops WW (2017) N-Acetylcysteine reduces cocaine-cue attentional bias and differentially alters cocaine self-administration based on dosing order. Drug Alcohol Depend 178:452–460
Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P (2013) The cystine/glutamate antiporter system xCT in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal 18(5):522–555
Li C, Shu Y, Wang G, Zhang H, Lu Y, Li X, Li G, Song L, Liu Z (2018) Characterizing a novel vGluT3-P2A-iCreER knock-in mouse strain in cochlea. Hear Res 364:12–24
Lin CH, Lin PP, Lin CY, Lin CH, Huang CH, Huang YJ, Lane HY (2016) Decreased mRNA expression for the two subunits of system xc(-), SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: evidence in support of the hypo-glutamatergic hypothesis of schizophrenia. J Psychiatr Res 72:58–63
Lisieski MJ, Karavidha K, Gheidi A, Garibyan RL, Conti AC, Morrow JD, Perrine SA (2019) Divergent effects of repeated cocaine and novel environment exposure on locus coeruleus c-fos expression and brain catecholamine concentrations in rats. Brain Behav 9(3):e01222. Epub ahead of print
Logica T, Riviere S, Holubiec MI, Castilla R, Barreto GE, Capani F (2016) Metabolic changes following perinatal asphyxia: role of astrocytes and their interaction with neurons. Front Aging Neurosci 8:116. https://doi.org/10.3389/fnagi.2016.00116
Madayag A, Lobner D, Kau KS, Mantsch JR, Abdulhameed O, Hearing M, Grier MD, Baker DA (2007) Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine. J Neurosci 27(51):13968–13976
Mahmoud S, Gharagozloo M, Simard C, Gris D (2019) Astrocytes maintain glutamate homeostasis in the CNS by controlling the balance between glutamate uptake and release. Cell 8(2):184
Mansouri-Guilani N, Bernard V, Vigneault E, Vialou V, Daumas S, El Mestikawy S, Gangarossa G (2019) VGLUT3 gates psychomotor effects induced by amphetamine. J Neurochem 148(6):779–795
Mark KA, Quinton MS, Russek SJ, Yamamoto BK (2007) Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release. J Neurosci 27(25):6823–6831
Markoutsa E, Xu P (2017) Redox potential sensitive N-acetylcysteine-prodrug nanoparticles inhibit the activation of microglia and improve neuronal survival. Mol Pharmacol 14(5):1591–1600
Mazaud D, Kottler B, Goncalves-Pimentel C, Proelss S, Tuchler N, Deneubourg C, Yuasa Y, Diebold C, Jungbluth H, Lai EC, Hirth F, Giangrande A, Fanto M (2019) Transcriptional regulation of the glutamate/GABA/glutamine cycle in adult glia controls motor activity and seizures in Drosophila. J Neurosci 39:5269–5283
McBride WJ (2002) Central nucleus of the amygdala and the effects of alcohol and alcohol-drinking behavior in rodents. Pharmacol Biochem Behav 71:509–515
McBride WJ, Murphy JM, Ikemoto S (1999) Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 101:129–152
McClintick JN, McBride WJ, Bell RL, Ding ZM, Liu Y, Xuei X, Edenberg HJ (2015) Gene expression changes in serotonin, GABA-A receptors, neuropeptides and ion channels in the dorsal raphe nucleus of adolescent alcohol-preferring (P) rats following binge-like alcohol drinking. Pharmacol Biochem Behav 129:87–96
McClure EA, Baker NL, Gipson CD, Carpenter MJ, Roper AP, Froeliger BE, Kalivas PW, Gray KM (2015) An open-label pilot trial of N-acetylcysteine and varenicline in adult cigarette smokers. Am J Drug Alcohol Abuse 41(1):52–56
Medrano MC, Mendiguren A, Pineda J (2015) Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus. Psychopharmacology 232(15):2795–2809
Moechars D, Weston MC, Leo S, Callaerts-Vegh Z, Goris I, Daneels G, Buist A, Cik M, van der Spek P, Kaas S, Meert T, D’Hooge R, Rosenmund C, Hampson RM (2006) Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain. J Neurosci 26(46):12055–12066
Morales M, Margolis EB (2017) Ventral tegmental area: cellular heterogeneity, connectivity and behaviour. Nat Rev Neurosci 18:73–85
Moran MM, McFarland K, Melendez RI, Kalivas PW, Seamans JK (2005) Cystine/glutamate exchange regulates metabotropic glutamate receptor presynaptic inhibition of excitatory transmission and vulnerability to cocaine seeking. J Neurosci 25:6389–6393
Moro F, Giannotti G, Caffino L, Marzo CM, Di Clemente A, Fumagalli F, Cervo L (2019) Lasting reduction of nicotine-seeking behavior by chronic N-acetylcysteine during experimental cue-exposure therapy. Addict Biol 27:e12771
Mousavi SG, Sharbafchi MR, Salehi M, Peykanpour M, Karimian Sichani N, Maracy M (2015) The efficacy of N-acetylcysteine in the treatment of methamphetamine dependence: a double-blind controlled, crossover study. Archives of Iranian Medicine 18(1):28–33
Moussawi K, Riegel A, Nair S, Kalivas PW (2011) Extracellular glutamate: functional compartments operate in different concentration ranges. Front Sys Neurosci 5:94
Murray JE, Everitt BJ, Belin D (2012) N-Acetylcysteine reduces early- and late-stage cocaine seeking without affecting cocaine taking in rats. Addict Biol 17(2):437–440
Nam HW, Mciver SR, Hinton DJ, Thakkar MM, Sari Y, Parkinson FE et al (2012) Adenosine and glutamate signaling in neuron-glia interactions: implications in alcoholism and sleep disorders. Alcohol Clin Exp Res 36:1117–1125
Namba MD, Kupchik YM, Spencer SM, Garcia-Keller C, Goenaga JG, Powell GL, Vicino IA, Hogue IB, Gipson CD (2019) Accumbens neuroimmune signaling and dysregulation of astrocytic glutamate transport underlie conditioned nicotine-seeking behavior. Addict Biol 22:e12797
Nocito Echevarria MA, Andrade Reis T, Ruffo Capatti G, Siciliano Soares V, da Silveira DX, Fidalgo TM (2017) N-acetylcysteine for treating cocaine addiction – A systematic review. Psychiatry Res 251:197–203
Nong Y, Huang YQ, Ju W, Kalia LV, Ahmadian G, Wang YT, Salter MW (2003) Glycine binding primes NMDA receptor internalization. Nature 422(6929):302–307
Otis JM, Zhu M, Namboodiri VM, Cook CA, Kosyk O, Matan AM, Ying R, Hashikawa Y et al (2019) Paraventricular thalamus projection neurons integrate cortical and hypothalamic signals for cue-reward processing. Neuron 103:423–431
Patten AR, Brocardo PS, Sakiyama C, Wortman RC, Noonan A, Gil-Mohapel J, Christie BR (2013) Impairments in hippocampal synaptic plasticity following prenatal ethanol exposure are dependent on glutathione levels. Hippocampus 23:1463–1475
Pei Y, Liu H, Yang Y, Yang Y, Jiao Y, Tay FR, Chen J (2018) Biological activities and potential oral applications of N-acetylcysteine: progress and prospects. Oxid Med Cell Longev 2018:2835787
Peters J, Kalivas PW, Quirk GJ (2009) Extinction circuits for fear and addiction overlap in the prefrontal cortex. Learn Mem 16:279–288
Philogene-Khalid HL, Simmons SJ, Muschamp JW, Rawls SM (2017) Effects of ceftriaxone on conditioned nicotine reward in rats. Behav Pharmacol 28(6):485–488
Pochini L, Scalise M, Galluccio M, Indiveri C (2014) Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health. Front Chem 2:61. https://doi.org/10.3389/fchem.2014.00061
Powell GL, Leyrer-Jackson JM, Goenaga J, Namba MD, Piña J, Spencer S, Stankeviciute N, Schwartz D, Allen NP, Del Franco AP, McClure EA, Olive MF, Gipson CD (2019) Chronic treatment with N-acetylcysteine decreases extinction responding and reduces cue-induced nicotine-seeking. Phys Rep 7(1):e13958
Qrunfleh AM, Alazizi A, Sari Y (2013) Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats. J Psychopharmacol 27:541–549
Quintanilla ME, Rivera-Meza M, Berríos-Cárcamo P, Salinas-Luypaert C, Herrera-Marschitz M, Israel Y (2016) Beyond the “First Hit”: Marked inhibition by N-Acetyl cysteine of chronic ethanol intake but not of early ethanol intake. Parallel effects on ethanol-induced saccharin motivation. Alcohol Clin Exp Res 40(5):1044–1051
Quintanilla ME, Morales P, Ezquer F, Ezquer M, Herrera-Marschitz M, Israel Y (2018) Commonality of ethanol and nicotine reinforcement and relapse in Wistar-derived UChB Rats: Inhibition by N-Acetylcysteine. Alcohol Clin Exp Res 42(10):1988–1999
Ramirez-Niño AM, D'Souza MS, Markou A (2013) N-acetylcysteine decreased nicotine self-administration and cue-induced reinstatement of nicotine seeking in rats: comparison with the effects of N-acetylcysteine on food responding and food seeking. Psychopharmacology 225(2):473–482
Rao P, Sari Y (2014) Effectiveness of ceftriaxone treatment in preventing relapse-like drinking behavior following long-term ethanol dependence in P Rats. J Addict Res Ther 5:1000183
Rao PSS, Bell RL, Engleman EA, Sari Y (2015) Targeting glutamate uptake to treat alcohol use disorders. Front Neurosci/Neuropharmacol 9:144
Rawls SM, Tallarida R, Robinson W, Amin M (2007) The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats. Br J Pharmacol 151:1095–1102
Rawls SM, Zielinski M, Patel H, Sacavage S, Baron DA, Patel D (2010) Beta-lactam antibiotic reduces morphine analgesic tolerance in rats through GLT-1 transporter activation. Drug Alcohol Depend 107(2–3):261–263
Reichel CM, Moussawi K, Do PH, Kalivas PW, See RE (2011) Chronic N-acetylcysteine during abstinence or extinction after cocaine self-administration produces enduring reductions in drug seeking. J Pharmacol Exp Ther 337(2):487–493
Reissner KJ, Kalivas PW (2010) Using glutamate homeostasis as a target for treating addictive disorders. Behav Pharmacol 21:514–522
Reissner KJ, Gipson CD, Tran PK, Knackstedt LA, Scofield MD, Kalivas PW (2015) Glutamate transporter GLT-1 mediates N-acetylcysteine inhibition of cocaine reinstatement. Addict Biol 20(2):316–323
Roberts-Wolfe DJ, Kalivas PW (2015) Glutamate transporter GLT-1 as a therapeutic target for substance use disorders. CNS Neurol Disord Drug Targets 14(6):745–756
Rothstein JD, Martin L, Levey AI, Dykes-Hoberg M, Jin L, Wu D, Nash N, Kuncl RW (1994) Localization of neuronal and glial glutamate transporters. Neuron 13:713–725
Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433(7021):73–77
Rowley NM, Madsen KK, Schousboe A, White HS (2012) Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control. Neurochem Int 61:546–558
Ryu N, Lee S, Park HJ, Lee B, Kwon TJ, Bok J, Park CI, Lee KY, Baek JI, Kim UK (2017) Identification of a novel splicing mutation within SLC17A8 in a Korean family with hearing loss by whole-exome sequencing. Gene 627:233–238
Sakae DY, Ramet L, Henrion A, Poirel O, Jamain S, El Mestikawy S, Daumas S (2019) Differential expression of VGLUT3 in laboratory mouse strains: impact on drug-induced hyperlocomotion and anxiety-related behaviors. Genes Brain Behav 18(3):e12528
Santus P, Corsico A, Solidoro P, Braido F, Di Marco F, Scichilone N (2014) Oxidative stress and respiratory system: pharmacological and clinical reappraisal of N-acetylcysteine. COPD 11(6):705–717
Sari Y (2013) Potential therapeutic role of glutamate transporter 1 for the treatment of alcohol dependence. OA Alcohol 1:6
Sari Y, Sreemantula SN (2012) Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats. Neuroscience 227:327–335
Sari Y, Smith KD, Ali PK, Rebec GV (2009) Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. J Neurosci 29(29):9239–9243
Sari Y, Sakai M, Weedman JM, Rebec GV, Bell RL (2011) Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats. Alcohol Alcohol 46:239–246
Sari Y, Franklin KM, Alazizi A, Rao PS, Bell RL (2013a) Effects of ceftriaxone on the acquisition and maintenance of ethanol drinking in peri-adolescent and adult female alcohol-preferring (P) rats. Neuroscience 241:229–238
Sari Y, Sreemantula SN, Lee MR, Choi DS (2013b) Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as ethanol intake in alcohol-preferring rats. J Mol Neurosci 51:779–787
Sari Y, Toalston JE, Rao PSS, Bell RL (2016) Effects of ceftriaxone on ethanol, nicotine or sucrose intake by alcohol-preferring (P) rats and its association with GLT-1 expression. Neuroscience 326:117–125
Schmaal L, Berk L, Hulstijn KP, Cousijn J, Wiers RW, van den Brink W (2011) Efficacy of N-acetylcysteine in the treatment of nicotine dependence: a double-blind placebo-controlled pilot study. Eur Addict Res 17(4):211–216
Schmidt WJ, Reith MEA (2005) Dopamine and glutamate in psychiatric disorders. Humana Press, Totowa, NJ
Schroeder JA, Tolman NG, McKenna FF, Watkins KL, Passeri SM, Hsu AH, Shinn BR, Rawls SM (2014) Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug? Drug Alcohol Depend 142:41–45
Schulte MHJ, Wiers RW, Boendermaker WJ, Goudriaan AE, van den Brink W, van Deursen DS, Friese M, Brede E, Waters AJ (2018) The effect of N-acetylcysteine and working memory training on cocaine use, craving and inhibition in regular cocaine users: correspondence of lab assessments and Ecological Momentary Assessment. Addict Behav 79:24–31
Schulte MHJ, Kaag AM, Boendermaker WJ, Brink WVD, Goudriaan AE, Wiers RW (2019) The effect of N-acetylcysteine and working memory training on neural mechanisms of working memory and cue reactivity in regular cocaine users. Psychiatry Res Neuroimaging 287:56–59
Scofield MD, Heinsbroek JA, Gipson CD, Kupchik YM, Spencer S, Smith AC, Roberts-Wolfe D, Kalivas PW (2016) The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis. Pharmacol Rev 68(3):816–871
Seo D, Funderburk SC, Bhatti DL, Motard LE, Newbold D, Girven KS, McCall JG, Krashes M, Sparta DR, Bruchas MR (2016) A GABAergic projection from the centromedial nuclei of the amygdala to ventromedial prefrontal cortex modulates reward behavior. J Neurosci 36:10831–10842
Shahripour RB, Harrigan MR, Alexandrov AV (2014) N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain and Behavior 4(2):108–122
Shen HW, Scofield MD, Boger H, Hensley M, Kalivas PW (2014) Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse. J Neurosci 34(16):5649–5657
Shigeri Y, Seal RP, Shimamoto K (2004) Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev 45(3):250–265
Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD (2003) Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology 165:359–369
Siggins GR, Martin G, Roberto M, Nie Z, Madamba S, De Lecea L (2003) Glutamatergic transmission in opiate and alcohol dependence. Ann N Y Acad Sci 1003:196–211
Sondheimer I, Knackstedt LA (2011) Ceftriaxone prevents the induction of cocaine sensitization and produces enduring attenuation of cue- and cocaine-primed reinstatement of cocaine-seeking. Behav Brain Res 225(1):252–258
Spencer S, Kalivas PW (2017) Glutamate transport: a new bench to bedside mechanism for treating drug abuse. Int J Neuropsychopharmacol 20(10):797–812
Spencer S, Scofield M, Kalivas PW (2016) The good and bad news about glutamate in drug addiction. J Psychopharmacol 30:1095–1098
Stennett BA, Frankowski JC, Peris J, Knackstedt LA (2017) Ceftriaxone reduces alcohol intake in outbred rats while upregulating xCT in the nucleus accumbens core. Pharmacol Biochem Behav 159:18–23
Stephans SE, Yamamoto BY (1995) Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res 700:99–106
Stewart SE, Mayerfeld C, Arnold PD, Crane JR, O’Dushlaine C, Fagerness JA et al (2013) Meta-analysis of association between obsessive-compulsive disorder and the 3’ region of neuronal glutamate transporter gene SLC1A1. Am J Med Genet B, Neuropsychiatr Genet 162B:367–379
Tabakoff B, Hoffman PL (2013) The neurobiology of alcohol consumption and alcoholism: an integrative history. Pharmacol Biochem Behav 113:20–37
Takamori S, Rhee JS, Rosenmund C, Jahn R (2000a) Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407(6801):189–194
Takamori S, Riedel D, Jahn R (2000b) Immunoisolation of GABA-specific synaptic vesicles defines a functionally distinct subset of synaptic vesicles. J Neurosci 20(13):4904–4911
Tanaka K (2000) Functions of glutamate transporters in the brain. Neurosci Res 37:15–19
Underhill SM, Wheeler DS, Li M, Watts SD, Ingram SL, Amara SG (2014) Amphetamine modulates excitatory neurotransmission through endocytosis of the glutamate transporter EAAT3 in dopamine neurons. Neuron 83:404–416
van der Hel WS, Verlinde SA, Meijer DH, de Wit M, Rensen MG, van Gassen KL, van Rijen PC, van Veelen CW, de Graan PN (2009) Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy. Epilepsia 50(7):1717–1728
Volkow ND, Morales M (2015) The brain on drugs: from reward to addiction. Cell 162(4):712–725
Volkow ND, Michaelides M, Baler R (2019) The neuroscience of drug reward and addiction. Physiol Rev 99:2115–2140
Wadiche JI, Amara SG, Kavanaugh MP (1995) Ion fluxes associated with excitatory amino acid transport. Neuron 15:721–728
Wang HL, Qi J, Zhang S, Wang H, Morales M (2015) Rewarding effects of optical stimulation of ventral tegmental area glutamatergic neurons. J Neurosci 35(48):15948–15954
Wang W, Zeng F, Hu Y, Li X (2019) A mini-review of the role of glutamate transporter in drug addiction. Front Neurol 10:1123
Wassum KM, Izquierdo A (2015) The basolateral amygdala in reward learning and addiction. Neurosci Biobehav Rev 57:271–283
Watts SD, Torres-Salazar D, Divito CB, Amara SG (2014) Cysteine transport through excitatory amino acid transporter 3 (EAAT3). PLoS One 9(10):e109245. https://doi.org/10.1371/journal.pone.0109245
Xue CJ, Ng JP, Li Y, Wolf ME (1996) Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem 67:352–363
Yang H, de Jong JW, Tak Y, Peck J, Bateup H, Lammel S (2018) Nucleus accumbens subnuclei regulate motivated behavior via direct inhibition and disinhibition of VTA dopamine subpopulations. Neuron 97:434–449
Zhang L-N, Wang Q, Xian X-H, Qi J, Liu L-Z, Li W-B (2019) Astrocytes enhance the tolerance of rat cortical neurons to glutamate excitotoxicity. Mol Med Rep 19(3):1521–1528
Zhou Y, Danbolt NC (2014) Glutamate as a neurotransmitter in the healthy brain. J Neural Transm (Vienna) 121(8):799–817
Zhou W, Kalivas PW (2008) N-acetylcysteine reduces extinction responding and induces enduring reductions in cue- and heroin-induced drug-seeking. Biol Psychiatry 63(3):338–340
Zhou FC, Sahr RN, Sari Y, Behbahani K (2006) Glutamate and dopamine synaptic terminals in extended amygdala after 14-week chronic alcohol drinking in inbred alcohol-preferring rats. Alcohol 39:39–49
Suggested Reading
Bell RL, Hauser SR, McClintick J, Rahman S, Edenberg HJ, Szumlinski KK, McBride WJ (2016) Ethanol-associated changes in glutamate reward neurocircutiry: a mini-review of clinical and preclinical genetic findings. In: Rahman S (ed) The molecular basis of drug addiction. [Progress in molecular biology and translational science, vol. 137]. Elsevier, New York, pp 41–85
Cui C, Grandison L, Noronha A (2013) Neural-immune interactions in brain function and alcohol related disorders. Springer, New York
Knackstedt LA, LaRowe S, Mardikian P, Malcolm R, Upadhyaya H, Hedden S, Markou A, Kalivas PW (2009) The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry 65(10):841–845
Noronha ABC, Cui C, Harris RA, Crabbe JC (2014) Neurobiology of alcohol dependence. Elsevier, Waltham, MA
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Deehan, G.A. et al. (2022). Pharmacological Role of Glutamate Transporters in Substance Use Disorders. In: Pavlovic, Z.M. (eds) Glutamate and Neuropsychiatric Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-87480-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-87480-3_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-87479-7
Online ISBN: 978-3-030-87480-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)